Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Bionano Genomics (Nasdaq: BNGO) announced that its CEO Erik Holmlin, PhD, will present at the H.C. Wainwright 27th Annual Global Investment Conference. The presentation is scheduled for September 8th, 2025, from 3:00 p.m. to 3:30 p.m. ET.
Investors can access the presentation through a webcast, and a replay will be available on Bionano's investor relations website at ir.bionano.com for a minimum of 30 days following the conference.
Bionano Genomics (Nasdaq: BNGO) ha annunciato che il suo CEO, Erik Holmlin, PhD, terrà una presentazione al H.C. Wainwright 27th Annual Global Investment Conference. L'intervento è programmato per 8 settembre 2025, dalle 15:00 alle 15:30 ET.
Gli investitori potranno seguire la presentazione via webcast; una registrazione sarà disponibile nella sezione investor relations di Bionano all'indirizzo ir.bionano.com per almeno 30 giorni dopo la conferenza.
Bionano Genomics (Nasdaq: BNGO) anunció que su CEO, Erik Holmlin, PhD, presentará en la H.C. Wainwright 27th Annual Global Investment Conference. La presentación está programada para el 8 de septiembre de 2025, de 3:00 p. m. a 3:30 p. m. ET.
Los inversores podrán acceder a la presentación mediante un webcast, y la repetición estará disponible en la web de relaciones con inversores de Bionano en ir.bionano.com durante al menos 30 días después de la conferencia.
Bionano Genomics (Nasdaq: BNGO)는 최고경영자(CEO)인 Erik Holmlin, PhD가 H.C. Wainwright 제27차 연례 글로벌 투자 컨퍼런스에서 발표할 예정이라고 발표했습니다. 발표 일정은 2025년 9월 8일 오후 3시부터 3시 30분(동부시간)입니다.
투자자들은 웨비캐스트를 통해 발표를 시청할 수 있으며, 컨퍼런스 종료 후 최소 30일 동안 Bionano의 투자자 관계 사이트 ir.bionano.com에서 재생 영상을 이용할 수 있습니다.
Bionano Genomics (Nasdaq: BNGO) a annoncé que son PDG, Erik Holmlin, PhD, présentera lors de la H.C. Wainwright 27th Annual Global Investment Conference. La présentation est prévue le 8 septembre 2025, de 15h00 à 15h30 (heure de l'Est).
Les investisseurs pourront suivre la présentation via un webcast ; un enregistrement sera disponible sur le site des relations investisseurs de Bionano, ir.bionano.com, pendant au moins 30 jours après la conférence.
Bionano Genomics (Nasdaq: BNGO) gab bekannt, dass sein CEO Erik Holmlin, PhD, auf der H.C. Wainwright 27th Annual Global Investment Conference auftreten wird. Die Präsentation ist für den 8. September 2025, von 15:00 bis 15:30 Uhr ET angesetzt.
Investoren können die Präsentation per Webcast verfolgen; eine Aufzeichnung wird für mindestens 30 Tage nach der Konferenz auf der Investor-Relations-Seite von Bionano unter ir.bionano.com verfügbar sein.
- None.
- None.
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8th, 2025.
Conference & Webcast Details
| Date: | September 8, 2025 |
| Time: | 3:00 p.m. to 3:30 p.m. ET |
| Presenter: | Erik Holmlin, PhD, CEO of Bionano |
| Webcast: | Link to Register |
A replay / recording of the session will be available following the conference through the Bionano website at ir.bionano.com for at least 30 days.
About Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.
For more information, visit www.bionano.com or www.bionanolaboratories.com.
Bionano’s products are for research use only and not for use in diagnostic procedures.
Contacts
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Kelly Gura
Gilmartin Group
+1 (212) 229-6163
IR@bionano.com
FAQ
When is Bionano Genomics (BNGO) presenting at the H.C. Wainwright Conference?
Who will represent Bionano Genomics (BNGO) at the H.C. Wainwright Conference?
How can investors access Bionano's (BNGO) H.C. Wainwright Conference presentation?
How long will the replay of Bionano's (BNGO) presentation be available?
